Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Universite Claude Bernard Lyon 1 (Ucbl) currently manages 1 pending office action within the Biotechnology & Pharmaceuticals technology area. This action is assigned to 1 distinct examiner, BAUER, NICOLA MARIA, and is being reviewed within 1 distinct art unit. This concentrated prosecution profile indicates that the university's current patent office activity is focused on a single technical matter and a single point of contact. Such a structure is common for institutions with a very specific technological focus.
The busiest examiner, BAUER, NICOLA MARIA, is responsible for 1 pending office action. As there is only 1 pending office action in total, this examiner is the sole official currently evaluating the university's pending intellectual property. The involvement of only 1 distinct art unit confirms that the prosecution is not spread across different technical departments. Consequently, the university's immediate prosecution success depends entirely on the interactions within this single art unit and with this specific examiner.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BAUER, NICOLA MARIA | 1 | 58.7% | +52.1% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18849056 | ORGANIC MOLECULES FOR TREATING MYELIN PATHOLOGIES | BAUER, NICOLA MARIA | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18849056 | ORGANIC MOLECULES FOR TREATING MYELIN PATHOLOGIES | BAUER, NICOLA MARIA | — |
| Art Unit | Apps |
|---|---|
| 1621 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18849056 | ORGANIC MOLECULES FOR TREATING MYELIN PATHOLOGIES | BAUER, NICOLA MARIA | 1621 | §102§103§112 | Non-Final OA | — | Pending | Sep 20, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialUniversite Claude Bernard Lyon 1 (Ucbl) has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Nicola Maria Bauer has the most, with 1 of Universite Claude Bernard Lyon 1 (Ucbl)'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
